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tated by  lipid-binding proteins or  through membrane- 
fusion events (1). Although a number of proteins have 
been  shown  to  function  in  cholesterol  movement,  the 











Abstract Niemann-Pick disease type C (NPC) disease is 
a lipid-storage disorder that is caused by mutations in the 
genes encoding NPC proteins and results in lysosomal 
cholesterol accumulation. 2-Hydroxypropyl--cyclodextrin 
(CD) has been shown to reduce lysosomal cholesterol lev-
els and enhance sterol homeostatic responses, but CD’s 
mechanism of action remains unknown. Recent work pro-
vides evidence that CD stimulates lysosomal exocytosis, 
raising the possibility that lysosomal cholesterol is released 
in exosomes. However, therapeutic concentrations of CD 
do not alter total cellular cholesterol, and cholesterol ho-
meostatic responses at the ER are most consistent with 
increased ER membrane cholesterol. To address these dis-
parate findings, here we used stable isotope labeling to 
track the movement of lipoprotein cholesterol cargo in 
response to CD in NPC1-deficient U2OS cells. Although 
released cholesterol was detectable, it was not associated 
with extracellular vesicles. Rather, we demonstrate that 
lysosomal cholesterol trafficks to the plasma membrane 
(PM), where it exchanges with lipoprotein-bound choles-
terol in a CD-dependent manner. We found that in the 
absence of suitable extracellular cholesterol acceptors, 
cholesterol exchange is abrogated, cholesterol accumulates 
in the PM, and reesterification at the ER is increased.  
These results support a model in which CD promotes in-
tracellular redistribution of lysosomal cholesterol, but not 
cholesterol exocytosis or efflux, during the restoration of 
cholesterol homeostatic responses.—Feltes, M., S. E. Gale, 
S. Moores, D. S. Ory, and  J. E. Schaffer. Monitoring the 
itinerary of lysosomal cholesterol in Niemann-Pick Type 
C1-deficient cells after cyclodextrin treatment. J. Lipid Res. 
2020. 61: 403–412.
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(acLDL) by the scavenger receptor A (SRA) are respon-
sible for cholesterol delivery into the lysosomal compart-



























cyclodextrin  (CD)  has  shown  great  promise  in  animal 
models and in human clinical trials (9). CD is a cyclic oligo-
saccharide frequently used as an excipient in drug formula-






















Our data  support  a model  in which CD promotes  the 
redistribution of lysosomal cholesterol to the PM, where 
it is exchanged with cholesterol carried by extracellular 




U2OS  cells  expressing  the  human  scavenger  receptor  A 
(U2OS-SRA)  and  U2OS-SRA  cells  with  shNPC1  knockdown 
(U2OS-SRAshNPC1)  were  a  gift  from  the Maxfield  Laboratory 







































Extraction of cholesterol and cholesteryl esters from 
isolated fractions, cell homogenates, and media
To extract lipids, a portion of the fraction, cell homogenate, or 
media was added to a 1:1:1:0.5 mixture of chloroform-methanol-





transferred  to  a  new  tube  for  the  derivatization  of  cholesterols 































PBS,  and  then  fixed  for  10 min  in  1%  glutaraldehyde.  Cells 
were washed twice more with PBS and then incubated in McCoy’s 
medium  containing  2  units/ml  cholesterol  oxidase  and  0.1 
units/ml sphingomyelinase  for 30 min at 37°C to convert PM 
cholesterol to cholestenone. Cells were washed again and then 
























teins were  separated on 4%  to 12% Bis-Tris precast  gels,  trans-
ferred to PVDF membranes, and probed for nuclear (lamin B1) 
and EV (CD63) markers.












































Lysate  fluorescence  was  quantified  using  a  TECAN  scanner  
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RESULTS
Lysosomal cholesterol is differentially distributed to the 










whole  body  in  6  h  (11),  and CD  is  estimated  to  reach 
concentrations of 0.1–1 mM in vivo (21, 22). On the basis 
of  these studies, we chose  to analyze  the effects of CD 
after 6 h of treatment with 0.5 mM CD. U2OS-SRAshNPC1 
cells  were  incubated with  d7-acLDL  in  the  presence  of 









SRAshNPC1  cells  expressing  TMEM192-RFP-HA,  a  tagged 
lysosomal protein, to quantify changes in lysosomal cho-


































resulted  in  a  2-fold  increase  in  the  formation  of  d16 
cholesteryl esters from cholesterol cargo originating in 
the lysosome (Fig. 2F). We also analyzed d7 cholesterol 
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ture medium as  early  as  3 h  after  lalistat washout  and 
CD treatment. Between 3 and 6 h, d7 cholesterol in the 
media increased 5-fold (Fig. 3A). The appearance of 
lysosomal  cholesterol  in  the  PM  preceded  its  appear-
ance  in  the  media  (Fig.  3B).  Similar  levels  of  PM  d7  
cholesterol  were measured  after  ionomycin  or  DMSO 
vehicle treatment. In contrast to CD, ionomycin did not 
promote  the  release of  the cholesterol  into  the media 






appearance  of  lysosomal  cholesterol  in  the  culture  me-
dium. To test whether d7 cholesterol arriving in the media 




with  CD.  The  EV  fraction  was  positive  for  the  exosome 
marker CD63 but negative for nuclear marker laminin B by 
Western blot (Fig. 3C, top). Similar results were seen with 
EVs  isolated  from  conditioned media  from  cells  treated 
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CD-induced accumulation of cholesterol in the media is 
















knockdown  cells  were  generated  using  target-specific 
(shABCA1-1 or shABCA1-2 and shABCG1-1 or shABCG1-2) 




knockdown  of  ABCA1  nor  knockdown  of  ABCG1  im-
paired d7 cholesterol accumulation in the media (Fig. 4E). 














and  EVs  for  exosomal  marker  CD63  and  nuclear 
marker LMB (C). Total d7 cholesterol in 27 ml con-
ditioned media  (input),  27 ml  EV-depleted media, 
and EVs (from 27 ml conditioned media) at 6 h (D). 
Total EV cholesterol normalized to EV protein (E). 
Means  ±  SEs  (n  =  3).  *P  <  0.05  by  unpaired  t-test. 
LMB, lamin B; V, vehicle.
Fig. 4.  CD-induced accumulation of cholesterol in 
the media  is  largely  independent of canonical  cell-






fied  by  LC/MS/MS.  A:  Representative  immunoblot 
for SRB1 with GAPDH loading control (above) and 
quantification for n = 3 (below). B: Moles released d7 
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CD-induced cholesterol accumulation in the media 









contained  two  dominant  species  that  comigrated  with 
either human LDL (Fig. 5A, lanes 1–4, upper band) or 
human HDL (Fig. 5A, lanes 1–4, lower band) on a native 
























the  media  if  lipoproteins  are  present,  or  further  traf-
ficked to the ER, where it is esterified.


































by  the  dynamin  inhibitor DYN,  consistent  with  a mecha-
nism of receptor-mediated endocytosis. The uptake of HDL 
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the  bidirectional movement  of  cholesterol  between  lipo-
proteins and the cell surface. Together these data support 
a model by which CD enhances the trafficking of lysosomal 
cholesterol  to  the PM, where  it  is  available  for exchange 
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